Expedia Group Slides as Investors Weigh Recent Bearish Analyst Call

Expedia Group (EXPE) is down 5.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be lingering pressure from a recent bearish analyst initiation rather than any new company-specific announcement today. This could be because investors are reassessing valuation after Morgan Stanley started coverage with an Underweight rating and a target far below where the shares had been trading.

Details:

Morgan Stanley initiated coverage of Expedia on September 16 with an Underweight rating and a $235 price target, citing weaker consumer assets, supplier direct-booking risk, and a valuation premium versus history.

Expedia’s recent public company updates do not show a fresh negative press release today; its investor relations page still points investors back to the August 5 second-quarter results and earlier September business updates.

The company’s latest quarterly materials showed solid second-quarter performance and a higher full-year outlook, which suggests today’s weakness is more about sentiment and valuation than a newly reported operational setback.

Recent SEC materials also do not indicate a new adverse filing tied to today’s move, reinforcing the view that the selloff may reflect continued digestion of the downgrade and profit-taking after a strong run earlier this year.

Sources:

SEC, Expedia Group Investor Relations, Google Finance

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$EXPE Insider Trading Activity

$EXPE insiders have traded $EXPE stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $EXPE stock by insiders over the last 6 months:

ROBERT J DZIELAK (Chief Legal Officer & Sec'y) has made 0 purchases and 4 sales selling 10,709 shares for an estimated $3,038,851.
LANCE A SOLIDAY (SVP & Chief Accounting Officer) has made 0 purchases and 2 sales selling 3,750 shares for an estimated $1,118,003.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive EXPE Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$EXPE Hedge Fund Activity

We have seen 585 institutional investors add shares of $EXPE stock to their portfolio, and 629 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 2,417,016 shares (+inf%) to their portfolio in Q2 2026, for an estimated $618,466,054
PACER ADVISORS, INC. added 1,414,534 shares (+inf%) to their portfolio in Q2 2026, for an estimated $361,950,959
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 746,684 shares (+inf%) to their portfolio in Q2 2026, for an estimated $191,061,501
ALKEON CAPITAL MANAGEMENT LLC removed 650,000 shares (-26.3%) from their portfolio in Q2 2026, for an estimated $166,322,000
FIRST TRUST ADVISORS LP added 637,669 shares (+53.5%) to their portfolio in Q2 2026, for an estimated $163,166,743
BRIDGEWATER ASSOCIATES, LP removed 591,187 shares (-94.9%) from their portfolio in Q2 2026, for an estimated $151,272,929
BARCLAYS PLC added 562,948 shares (+90.9%) to their portfolio in Q2 2026, for an estimated $144,047,134

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$EXPE Congressional Stock Trading

Members of Congress have traded $EXPE stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $EXPE stock by members of Congress over the last 6 months:

SENATOR ALAN ARMSTRONG sold up to $50,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$EXPE Analyst Ratings

Wall Street analysts have issued reports on $EXPE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 05/08/2026

To track analyst ratings and price targets for $EXPE, check out Quiver Quantitative's $EXPE forecast page.

$EXPE Price Targets

Multiple analysts have issued price targets for $EXPE recently. We have seen 12 analysts offer price targets for $EXPE in the last 6 months, with a median target of $277.0.

Here are some recent targets:

John Staszak from Argus Research set a target price of $315.0 on 07/07/2026
Ken Gawrelski from Wells Fargo set a target price of $303.0 on 06/30/2026
Jake Fuller from BTIG set a target price of $330.0 on 06/09/2026
Tom White from DA Davidson set a target price of $250.0 on 05/18/2026
Shyam Patil from Susquehanna set a target price of $250.0 on 05/11/2026
Trevor Young from Barclays set a target price of $264.0 on 05/11/2026
Stephen Ju from UBS set a target price of $262.0 on 05/08/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.